Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer.

Clinical chemistry - 1 May 2004

O'Hara S Mark, Moreno Jose G, Zweitzig Daniel R, Gross Steve, Gomella Leonard G, Terstappen Leon W M M

Abstract excerpt

BACKGROUND: Circulating tumor cells (CTCs) represent a surrogate source of tissue and conceptually represent a "real-time" biopsy. We previously reported that the number of CTCs mirrors disease progression in hormone-refractory prostate cancer (HRPC). To improve characterization of CTCs we further investigated whether in vitro transcription-based multigene reverse transcription-PCR expression profiles could be...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Count
Share to Gene Expression Profiling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunomagnetic Separation

Share to Neoplastic Cells, Circulating

Share to Prostatic Neoplasms

Share to Reverse Transcriptase Polymerase Chain Reaction

Share to RNA, Antisense

Share to Treatment Failure

Source

Identifiers

PMID: 14988224
DOI: 10.1373/clinchem.2003.028563

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer.PMID 14988224Read ↗

Single cell transcriptomic analysis of prostate cancer cellsSemantic proximity Read ↗

Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancerSemantic proximity Read ↗

A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancerSemantic proximity Read ↗

Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markersSemantic proximity Read ↗

Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer.Semantic proximity Read ↗

RNA-Seq following PCR-based sorting reveals rare cell transcriptional signaturesSemantic proximity Read ↗

RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistanceSemantic proximity Read ↗

Detection and phenotyping of circulating tumor cells in high-risk localized prostate cancer.Semantic proximity Read ↗

Low Abundance of Circulating Tumor DNA in Localized Prostate CancerSemantic proximity Read ↗

Detection of CTC Clusters and a Dedifferentiated RNA‐Expression Survival Signature in Prostate CancerSemantic proximity Read ↗

RNA profiling of circulating tumor cells systemically captured from diagnostic leukapheresis products in prostate cancer patientsSemantic proximity Read ↗

Comparative Analysis of AR Variant AR-V567es mRNA Detection Systems Reveals Eminent Variability and Questions the Role as a Clinical Biomarker in Prostate CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.